Evidence mapPaperPMID 41977086Full record

ReviewJournal of clinical medicine2026

Beyond Glycemic Control: GLP-1RA-Based Therapies and Emerging Targets Beyond the Metabolic Axis.

Wojciech Matuszewski, Katarzyna Wołos-Kłosowicz, Paulina Włodarczyk, Patrycja Waśniewska, Robert Modzelewski, Jan Marek Górny, Michał Szklarz, Mikołaj Madeksza, Judyta Juranek

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wojciech MatuszewskiClinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-719 Olsztyn, Poland.ORCID 0000-0001-8279-0373
Katarzyna Wołos-KłosowiczClinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-719 Olsztyn, Poland.
Paulina WłodarczykDepartment of Human Physiology and Pathophysiology, University of Warmia and Mazury, 10-719 Olsztyn, Poland.
Patrycja WaśniewskaDepartment of Human Physiology and Pathophysiology, University of Warmia and Mazury, 10-719 Olsztyn, Poland.
Robert ModzelewskiClinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-719 Olsztyn, Poland.
Jan Marek GórnyClinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-719 Olsztyn, Poland.ORCID 0009-0004-8167-6658
Michał SzklarzClinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-719 Olsztyn, Poland.
Mikołaj MadekszaClinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-719 Olsztyn, Poland.ORCID 0009-0005-4793-8711
Judyta JuranekDepartment of Human Physiology and Pathophysiology, University of Warmia and Mazury, 10-719 Olsztyn, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

addictioncancerGLP-1 receptor agonistsmental healthneuroprotectionpolycystic ovary syndrome (PCOS)

Identifiers

PMID41977086
PMCPMC13073043

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.